|
2025
|
Invention
|
Inhibitor of the flavin-containing monooxygenase (fmo) for use in the treatment of cancer. in vit... |
|
2024
|
Invention
|
Core/shell radioactive nanoparticles useful in targeted radiotherapy. The present invention relat... |
|
|
Invention
|
Method for the diagnosis of a cancer with chromatin-bound mdm2. The disclosure relates to the in ... |
|
|
Invention
|
Metabolites for trna modification. In general, the current disclosure relates to pre-queuosine1 (... |
|
|
Invention
|
Anti-cathepsin-d antibodies. The inventors generated a new anti-Cath-D antibody (F1M1) which is a... |
|
|
Invention
|
New 5h-pyrrolo[3,2-b:5,4-c']dipyridine derivatives and 6,7,8,9-tetrahydro-5h-pyrrolo[3,2-b:5,4-c'... |
|
2023
|
Invention
|
Biomaterial for use in the dental field. The present invention relates to a crosslinkable polymer... |
|
|
Invention
|
Anti-slc1a4 monoclonal antibodies and uses thereof. in vitro in vivo in vivo use of the anti-SLC1... |
|
|
Invention
|
Methods for screening a subject for a cancer.
Methods for screening a subject for a cancer are p... |
|
|
Invention
|
Method for treating prostate cancer and other epithelial cancers. The present invention relates t... |
|
|
Invention
|
Antibodies having specificity to ltbp2 and uses thereof. The present invention relates to the tre... |
|
|
Invention
|
Syk inhibitors for use in the treatment of cancer. In vitroin vivoin vivo. |
|
|
Invention
|
Method for screening a subject for cancer.
The present invention relates to the diagnostic of ca... |
|
|
Invention
|
Bispecific antibodies binding to her-3 and to either her-2 or egfr.
The present invention relate... |
|
|
Invention
|
Bispecific antibodies binding to her-3 and to either her-2 or egfr. The present invention relates... |
|
|
Invention
|
Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancer.
There is an... |
|
|
Invention
|
Anti-robo4 human monoclonal antibodies and uses thereof for the treatment of cancer. There is an ... |
|
|
Invention
|
Method for diagnosing colorectal cancer. The present invention relates to the diagnosing of color... |
|
2022
|
Invention
|
Methods and compositions for treating triple negative breast cancer (tnbc).
Inventors analyzed t... |
|
|
Invention
|
Methods and compositions for treating triple negative breast cancer (tnbc). Inventors analyzed th... |
|
|
Invention
|
New method to diagnose inflammatory diseases.
The present invention relates to the diagnostic of... |
|
|
Invention
|
Methods for the treatment of cancer.
The present disclosure relates to an Interleukin-6 (IL-6) s... |
|
|
Invention
|
New method to diagnose inflammatory diseases. The present invention relates to the diagnostic of ... |
|
|
Invention
|
Method for diagnosing pancreatic cancer.
The present invention relates to the diagnostics of pan... |
|
|
Invention
|
Method for diagnosing pancreatic cancer. The present invention relates to the diagnostics of panc... |
|
2021
|
Invention
|
C-terminal sparc fragments for treating cancer.
Tumour-specific molecular targets and alternativ... |
|
|
Invention
|
C-terminal sparc fragments for treating cancer. Tumour-specific molecular targets and alternative... |
|
|
Invention
|
Methods for determining the quality of an embryo.
The present invention relates generally to the... |
|
|
Invention
|
Method for predicting the survival time of a patient suffering from a cancer.
The present invent... |
|
|
Invention
|
Method for predicting the survival time of a patient suffering from a cancer. ϒϒϒδ T cells infilt... |
|
2020
|
Invention
|
Antibodies having specificity to her4 and uses thereof.
The present invention relates to antibod... |
|
|
Invention
|
Antibodies having specificity to her4 and uses thereof. The present invention relates to antibodi... |
|
|
Invention
|
Anti-müllerian inhibiting substance antibodies and uses thereof. In ovarian carcinoma, Müllerian ... |
|
|
Invention
|
Use of müllerian inhibiting substance inhibitors for treating cancer.
In ovarian carcinoma, Müll... |
|
|
Invention
|
Anti-müllerian inhibiting substance type i receptor antibodies and uses thereof. The present disc... |
|
|
Invention
|
Use of müllerian inhibiting substance inhibitors for treating cancer. In ovarian carcinoma, Mülle... |
|
|
Invention
|
Antibodies specific for il20-rb and uses thereof for the treatment of acute exacerbation of chron... |
|
|
Invention
|
Method for screening a subject for a cancer.
The present invention relates to the field of cance... |
|
|
Invention
|
Method for screening a subject for a cancer. The present invention relates to the field of cancer... |
|
|
Invention
|
In vitro method for assessing the risk of prostate side effect after treatment by ionizing radiat... |
|
2019
|
Invention
|
Methods and compositions for treating cancers by immuno-modulation using antibodies against cathe... |
|
|
Invention
|
Bispecific antibody targeting transferrin receptor 1 and soluble antigen.
The invention relates ... |
|
|
Invention
|
Combination for treating cancer.
The present invention relates to the treatment of cancer and pa... |
|
|
Invention
|
Methods and kits for detecting egfr mutations.
The present invention relates to methods, materia... |
|
2018
|
Invention
|
Method for screening and treating a subject for a cancer. The present invention relates to the di... |
|
2017
|
Invention
|
In vitro method for predicting the risk of developing a breast late effect after radiotherapy.
T... |
